Cargando…
Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria
PURPOSE: The aim of the present study was to evaluate the per-lesion sensitivity and specificity of the Korean Liver Cancer Association–National Cancer Center (KLCA-NCC) 2022 criteria for the noninvasive diagnosis of hepatocellular carcinoma (HCC), with intraindividual comparison of the diagnostic p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372598/ https://www.ncbi.nlm.nih.gov/pubmed/36791769 http://dx.doi.org/10.4143/crt.2022.1645 |
_version_ | 1785078403664183296 |
---|---|
author | Yoon, Ja Kyung Han, Dai Hoon Lee, Sunyoung Choi, Jin-Young Choi, Gi Hong Kim, Do Young Kim, Myeong-Jin |
author_facet | Yoon, Ja Kyung Han, Dai Hoon Lee, Sunyoung Choi, Jin-Young Choi, Gi Hong Kim, Do Young Kim, Myeong-Jin |
author_sort | Yoon, Ja Kyung |
collection | PubMed |
description | PURPOSE: The aim of the present study was to evaluate the per-lesion sensitivity and specificity of the Korean Liver Cancer Association–National Cancer Center (KLCA-NCC) 2022 criteria for the noninvasive diagnosis of hepatocellular carcinoma (HCC), with intraindividual comparison of the diagnostic performance of magnetic resonance imaging with extracellular agents (ECA-MRI) and hepatobiliary agents (HBA-MRI). MATERIALS AND METHODS: Patients at high risk for HCC who were referred to a tertiary academic institution for hepatic lesions with size ≥ 10 mm between July 2019 and June 2022 were enrolled. A total of 91 patients (mean age, 58.1 years; 76 men and 15 women) with 118 lesions who underwent both ECA-MRI and HBA-MRI were eligible for final analysis. The per-lesion sensitivities and specificities of the KLCA-NCC 2022 criteria using ECA-MRI and HBA-MRI were compared using McNemar’s test. RESULTS: The 118 lesions were 93 HCCs, 4 non-HCC malignancies, and 21 benign lesions. On HBA-MRI, the “definite” HCC category showed significantly higher sensitivity than ECA-MRI (78.5% vs. 58.1%, p < 0.001), with identical specificity (92.0% vs. 92.0%, p > 0.999). For “probable” or “definite” HCC categories, there were no differences in the sensitivity (84.9% vs. 84.9%, p > 0.999) and specificity (84.0% vs. 84.0%, p > 0.999) between ECA-MRI and HBA-MRI. CONCLUSION: The “definite” HCC category of the KLCA-NCC 2022 criteria showed higher sensitivity in diagnosing HCC on HBA-MRI compared with ECA-MRI, without compromising specificity. There were no significant differences in the sensitivity and specificity of “probable” or “definite” HCC categories according to ECA-MRI and HBA-MRI. |
format | Online Article Text |
id | pubmed-10372598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Korean Cancer Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-103725982023-07-28 Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria Yoon, Ja Kyung Han, Dai Hoon Lee, Sunyoung Choi, Jin-Young Choi, Gi Hong Kim, Do Young Kim, Myeong-Jin Cancer Res Treat Original Article PURPOSE: The aim of the present study was to evaluate the per-lesion sensitivity and specificity of the Korean Liver Cancer Association–National Cancer Center (KLCA-NCC) 2022 criteria for the noninvasive diagnosis of hepatocellular carcinoma (HCC), with intraindividual comparison of the diagnostic performance of magnetic resonance imaging with extracellular agents (ECA-MRI) and hepatobiliary agents (HBA-MRI). MATERIALS AND METHODS: Patients at high risk for HCC who were referred to a tertiary academic institution for hepatic lesions with size ≥ 10 mm between July 2019 and June 2022 were enrolled. A total of 91 patients (mean age, 58.1 years; 76 men and 15 women) with 118 lesions who underwent both ECA-MRI and HBA-MRI were eligible for final analysis. The per-lesion sensitivities and specificities of the KLCA-NCC 2022 criteria using ECA-MRI and HBA-MRI were compared using McNemar’s test. RESULTS: The 118 lesions were 93 HCCs, 4 non-HCC malignancies, and 21 benign lesions. On HBA-MRI, the “definite” HCC category showed significantly higher sensitivity than ECA-MRI (78.5% vs. 58.1%, p < 0.001), with identical specificity (92.0% vs. 92.0%, p > 0.999). For “probable” or “definite” HCC categories, there were no differences in the sensitivity (84.9% vs. 84.9%, p > 0.999) and specificity (84.0% vs. 84.0%, p > 0.999) between ECA-MRI and HBA-MRI. CONCLUSION: The “definite” HCC category of the KLCA-NCC 2022 criteria showed higher sensitivity in diagnosing HCC on HBA-MRI compared with ECA-MRI, without compromising specificity. There were no significant differences in the sensitivity and specificity of “probable” or “definite” HCC categories according to ECA-MRI and HBA-MRI. Korean Cancer Association 2023-07 2023-02-10 /pmc/articles/PMC10372598/ /pubmed/36791769 http://dx.doi.org/10.4143/crt.2022.1645 Text en Copyright © 2023 by the Korean Cancer Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Yoon, Ja Kyung Han, Dai Hoon Lee, Sunyoung Choi, Jin-Young Choi, Gi Hong Kim, Do Young Kim, Myeong-Jin Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria |
title | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria |
title_full | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria |
title_fullStr | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria |
title_full_unstemmed | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria |
title_short | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria |
title_sort | intraindividual comparison of mris with extracellular and hepatobiliary contrast agents for the noninvasive diagnosis of hepatocellular carcinoma using the korean liver cancer association–national cancer center 2022 criteria |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372598/ https://www.ncbi.nlm.nih.gov/pubmed/36791769 http://dx.doi.org/10.4143/crt.2022.1645 |
work_keys_str_mv | AT yoonjakyung intraindividualcomparisonofmriswithextracellularandhepatobiliarycontrastagentsforthenoninvasivediagnosisofhepatocellularcarcinomausingthekoreanlivercancerassociationnationalcancercenter2022criteria AT handaihoon intraindividualcomparisonofmriswithextracellularandhepatobiliarycontrastagentsforthenoninvasivediagnosisofhepatocellularcarcinomausingthekoreanlivercancerassociationnationalcancercenter2022criteria AT leesunyoung intraindividualcomparisonofmriswithextracellularandhepatobiliarycontrastagentsforthenoninvasivediagnosisofhepatocellularcarcinomausingthekoreanlivercancerassociationnationalcancercenter2022criteria AT choijinyoung intraindividualcomparisonofmriswithextracellularandhepatobiliarycontrastagentsforthenoninvasivediagnosisofhepatocellularcarcinomausingthekoreanlivercancerassociationnationalcancercenter2022criteria AT choigihong intraindividualcomparisonofmriswithextracellularandhepatobiliarycontrastagentsforthenoninvasivediagnosisofhepatocellularcarcinomausingthekoreanlivercancerassociationnationalcancercenter2022criteria AT kimdoyoung intraindividualcomparisonofmriswithextracellularandhepatobiliarycontrastagentsforthenoninvasivediagnosisofhepatocellularcarcinomausingthekoreanlivercancerassociationnationalcancercenter2022criteria AT kimmyeongjin intraindividualcomparisonofmriswithextracellularandhepatobiliarycontrastagentsforthenoninvasivediagnosisofhepatocellularcarcinomausingthekoreanlivercancerassociationnationalcancercenter2022criteria |